Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 7
2005 3
2006 4
2008 4
2009 10
2010 6
2011 9
2012 9
2013 4
2014 7
2015 4
2016 9
2017 1
2018 4
2019 7
2020 5
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Actions and Regulation of Ionotropic Cannabinoid Receptors.
De Petrocellis L, Nabissi M, Santoni G, Ligresti A. De Petrocellis L, et al. Among authors: ligresti a. Adv Pharmacol. 2017;80:249-289. doi: 10.1016/bs.apha.2017.04.001. Epub 2017 Jun 12. Adv Pharmacol. 2017. PMID: 28826537 Review.
Endocannabinoid metabolic pathways and enzymes.
Ligresti A, Cascio MG, Di Marzo V. Ligresti A, et al. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):615-23. doi: 10.2174/156800705774933104. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375679 Review.
The endocannabinoid signalling system: biochemical aspects.
Bisogno T, Ligresti A, Di Marzo V. Bisogno T, et al. Among authors: ligresti a. Pharmacol Biochem Behav. 2005 Jun;81(2):224-38. doi: 10.1016/j.pbb.2005.01.027. Pharmacol Biochem Behav. 2005. PMID: 15935454 Review.
New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators.
Montanari S, Allarà M, Scalvini L, Kostrzewa M, Belluti F, Gobbi S, Naldi M, Rivara S, Bartolini M, Ligresti A, Bisi A, Rampa A. Montanari S, et al. Among authors: ligresti a. Molecules. 2021 May 28;26(11):3254. doi: 10.3390/molecules26113254. Molecules. 2021. PMID: 34071439 Free PMC article.
Synthesis of the Major Mammalian Metabolites of THCV.
Tinto F, Villano R, Kostrzewa M, Ligresti A, Straker H, Manzo E. Tinto F, et al. Among authors: ligresti a. J Nat Prod. 2020 Jul 24;83(7):2060-2065. doi: 10.1021/acs.jnatprod.9b00831. Epub 2020 Jul 10. J Nat Prod. 2020. PMID: 32649196
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R. Chiodelli P, et al. Among authors: ligresti a. Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1. Cancer Lett. 2022. PMID: 34861311
101 results